1. Home
  2. SOFI vs NTRA Comparison

SOFI vs NTRA Comparison

Compare SOFI & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOFI
  • NTRA
  • Stock Information
  • Founded
  • SOFI 2011
  • NTRA 2003
  • Country
  • SOFI United States
  • NTRA United States
  • Employees
  • SOFI N/A
  • NTRA N/A
  • Industry
  • SOFI Diversified Financial Services
  • NTRA Medical Specialities
  • Sector
  • SOFI Finance
  • NTRA Health Care
  • Exchange
  • SOFI Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • SOFI 17.8B
  • NTRA 20.6B
  • IPO Year
  • SOFI N/A
  • NTRA 2015
  • Fundamental
  • Price
  • SOFI $15.22
  • NTRA $161.01
  • Analyst Decision
  • SOFI Hold
  • NTRA Strong Buy
  • Analyst Count
  • SOFI 16
  • NTRA 15
  • Target Price
  • SOFI $10.50
  • NTRA $152.67
  • AVG Volume (30 Days)
  • SOFI 49.6M
  • NTRA 1.2M
  • Earning Date
  • SOFI 01-27-2025
  • NTRA 11-12-2024
  • Dividend Yield
  • SOFI N/A
  • NTRA N/A
  • EPS Growth
  • SOFI N/A
  • NTRA N/A
  • EPS
  • SOFI 0.12
  • NTRA N/A
  • Revenue
  • SOFI $2,519,211,000.00
  • NTRA $1,531,955,000.00
  • Revenue This Year
  • SOFI N/A
  • NTRA $53.06
  • Revenue Next Year
  • SOFI $18.06
  • NTRA $11.04
  • P/E Ratio
  • SOFI $129.56
  • NTRA N/A
  • Revenue Growth
  • SOFI 32.15
  • NTRA 54.94
  • 52 Week Low
  • SOFI $6.01
  • NTRA $58.53
  • 52 Week High
  • SOFI $17.19
  • NTRA $175.63
  • Technical
  • Relative Strength Index (RSI)
  • SOFI 50.34
  • NTRA 45.49
  • Support Level
  • SOFI $15.14
  • NTRA $153.53
  • Resistance Level
  • SOFI $17.19
  • NTRA $172.80
  • Average True Range (ATR)
  • SOFI 0.88
  • NTRA 5.91
  • MACD
  • SOFI -0.29
  • NTRA -2.98
  • Stochastic Oscillator
  • SOFI 17.24
  • NTRA 8.17

About SOFI SoFi Technologies Inc.

SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: